67 results
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
; Governmental Proceedings. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding … , regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
Litigation; Governmental Proceedings. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental … administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
on the Transactions
Section 5.22
Investigation
Article 6. REPRESENTATIONS AND WARRANTIES OF BUYER AND MERGER SUB
Section 6.1
Organization of Buyer; Due Authorization …
Section 6.6
Brokers
Section 6.7
Investigation
Article 7. ADDITIONAL AGREEMENTS
Section 7.1
Stockholder’s Meeting
ii
Section 7.2
Proxy Statement
8-K
EX-10.11
ATXI
Avenue Therapeutics Inc
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
diligence investigation within the meaning of the Securities Act with respect to any applicable Registration Statement;provided,that such Inspectors agree … of the aggregate amount paid in settlement of any litigation, or investigation or proceeding by any governmental agency or body, commenced or threatened, or of any
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding … , inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any
10-12G
EX-10.1
hb0dsf18cad ad88c1
12 Jan 17
Registration of securities
12:00am
10-12G/A
EX-10.1
y50ur
18 Feb 16
Registration of securities (amended)
12:00am
10-12G/A
EX-10.1
x6i9giljn7z
13 Mar 17
Registration of securities (amended)
12:00am
8-K
EX-10.1
qtty9m1qom5 9tqk
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
10-12G
EX-10.5
54u4ifb9
30 Dec 15
Registration of securities
12:00am
10-12G
EX-10.5
zdmqgph38im5
12 Jan 17
Registration of securities
12:00am
PREM14A
01hjcohxi949uea
11 Dec 18
Preliminary proxy related to merger
5:23pm